In a move utterly devoid of shock value to Catholics who have been paying attention at all, the Vatican has announced plans to fund NeoStem, a small adult stem cell research company in New York. According to the Los Angeles Times,
[NeoStem CEO Dr. Robin] Smith . . . was quick to emphasize that the Vatican is not investing in her company, which is publicly traded on the New York Stock Exchange. Most of the collaboration will involve a nonprofit company established by NeoStem, the Stem for Life Foundation, she said. The Vatican’s role will include fundraising, launching educational campaigns, contributing to research and sponsoring the Rome conference, Smith said.
The Vatican signed a $1...READ MORE